These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3105418

  • 1. Toxicity and pathological effects of a new dosage form of mitomycin C for carcinomatous peritonitis.
    Hagiwara A, Takahashi T, Ueda T, Lee R, Takeda M, Itoh T.
    Anticancer Res; 1987; 7(1):105-8. PubMed ID: 3105418
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhanced anticancer efficacy by use of mitomycin C adsorbed on small activated carbon particles in mice.
    Hagiwara A, Takahashi T, Ueda T, Nakagawa Y.
    Jpn J Cancer Res; 1987 Apr; 78(4):405-8. PubMed ID: 3108220
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Intraabdominal administration of MMC adsorbed on activated carbon for management of carcinomatous peritonitis].
    Takahashi T, Hagiwara A, Ito T.
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1550-6. PubMed ID: 6433797
    [Abstract] [Full Text] [Related]

  • 7. Activated carbon particles as anti-cancer drug carrier into regional lymph nodes.
    Hagiwara A, Takahashi T, Ueda T, Iwamoto A, Torii T.
    Anticancer Drug Des; 1987 Apr; 1(4):313-21. PubMed ID: 2453199
    [Abstract] [Full Text] [Related]

  • 8. [Targeting chemotherapy with activated carbon particles adsorbing anti-cancer drugs].
    Hagiwara A, Takahashi T, Kondoh S, Iwamoto A, Sawai K.
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1038-42. PubMed ID: 2455477
    [Abstract] [Full Text] [Related]

  • 9. [Intraoperative chemotherapy with intraperitoneal activated carbon particles adsorbing mitomycin C against peritoneal dissemination of gastric cancer].
    Iwamoto A, Takahashi T, Sasabe T, Itoh M, Kondoh S, Seiki K, Yoneyama C, Shimotsuma M, Hagiwara A, Yamaguchi T.
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2748-51. PubMed ID: 2506820
    [Abstract] [Full Text] [Related]

  • 10. Animal experiments as a model for clinical trials of a new dosage form of mitomycin C for peritoneal carcinomatosis.
    Hagiwara A, Takahashi T, Lee R, Ueda T, Takeda M, Itoh T.
    In Vivo; 1987 Aug; 1(1):43-6. PubMed ID: 2979763
    [Abstract] [Full Text] [Related]

  • 11. Selective delivery of high levels of mitomycin C to peritoneal carcinomatosis using a new dosage form.
    Hagiwara A, Takahashi T, Lee R, Ueda T, Takeda M, Itoh T.
    Anticancer Res; 1986 Aug; 6(5):1161-4. PubMed ID: 3099630
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy for carcinomatous peritonitis and pleuritis with MMC-CH, mitomycin C adsorbed on activated carbon particles. Clinical trials.
    Hagiwara A, Takahashi T, Lee R, Ueda T, Takeda M, Itoh T.
    Cancer; 1987 Jan 15; 59(2):245-51. PubMed ID: 3100014
    [Abstract] [Full Text] [Related]

  • 13. [Effect on immunological response of host by mitomycin C adsorbed into activated carbon particles (MMC-CH) in mice].
    Iwamoto A, Sakita M, Hata K, Hagiwara A, Takahashi T.
    Nihon Geka Gakkai Zasshi; 1989 Nov 15; 90(11):1829-33. PubMed ID: 2514342
    [Abstract] [Full Text] [Related]

  • 14. [Chemotherapy of carcinomatous peritonitis and carcinomatous pleuritis by using activated charcoal particle adsorbing mitomycin C (MMC-CH)--studies on the clinical trials].
    Hagiwara A, Takahashi T, Lee R, Ueda T, Takeda M, Itoh T.
    Nihon Gan Chiryo Gakkai Shi; 1985 Oct 20; 20(9):2144-53. PubMed ID: 3937878
    [No Abstract] [Full Text] [Related]

  • 15. [Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma].
    Qu QL, Zhang YG, Yang LZ, Sun L.
    Zhonghua Zhong Liu Za Zhi; 2006 Apr 20; 28(4):257-60. PubMed ID: 16875622
    [Abstract] [Full Text] [Related]

  • 16. Effects of intraperitoneal mitomycin C adsorbed on activated carbon on adhesion formation and mesothelial cells in vitro.
    Jansen M, Fass J, Langejürgen E, Forsch S, Tietze L, Schumpelick V.
    Eur J Surg; 2000 Jul 20; 166(7):572-6. PubMed ID: 10965838
    [Abstract] [Full Text] [Related]

  • 17. [Pharmacokinetic study of intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles].
    Liang H, Tang HW, Hao XS, Sun H, Li W.
    Zhonghua Zhong Liu Za Zhi; 2005 Jul 20; 27(7):412-5. PubMed ID: 16188126
    [Abstract] [Full Text] [Related]

  • 18. Anticancer agents adsorbed by activated carbon particles, a new form of dosage enhancing efficacy on lymphnodal metastases.
    Hagiwara A, Ahn T, Ueda T, Iwamoto A, Ueda T, Torii T, Takahashi T.
    Anticancer Res; 1986 Jul 20; 6(5):1005-8. PubMed ID: 2432828
    [Abstract] [Full Text] [Related]

  • 19. Chemocoagulation of metastatic lymph nodes using a suspension of mitomycin C-adsorbing activated carbon particles in 80% ethanol.
    Seiki K, Takahashi T, Sawai K, Okano S, Hagiwara A.
    Cancer Invest; 1993 Jul 20; 11(4):379-87. PubMed ID: 8324642
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivative.
    Bradner WT, Rose WC, Schurig JE, Florczyk AP, Huftalen JB, Catino JJ.
    Cancer Res; 1985 Dec 20; 45(12 Pt 1):6475-81. PubMed ID: 3933826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.